NEW YORK (GenomeWeb News) – The National Human Genome Research Institute has awarded BioNanomatrix a $397,750 research grant to develop its nanoscale whole genome imaging platform, the company said today.
BioNanomatrix is developing a system that allows nanoscale single molecule identification and analysis of the entire genome. The system’s ability to deliver single molecule sensitivity in a highly parallel format with minimal processing will reduce cost and time spent on extensive data and integrative analyses, the company said.
The NHGRI awarded the two-year Small Business Investment Research grant under the NIH BioEngineering Nanotechnology Initiative.
This is BioNanomatrix’s second NIH grant this year. The company received a National Cancer Institute grant in May to develop a cancer diagnostic prototype.